Mr. Siddhartha Sankaran will remain CFO through that date.
Key facts
Extracted from this filing and checked against the source text.
Earnings ReleasesSEC 8-K Item 2.02confidence 0.9
Oscar Health, Inc. updated its full year 2023 guidance (reaffirmed).
Period
full year 2023
Guidance
reaffirmed
Result
guidance update
Exact text from the filing
Oscar is reaffirming its full year 2023 outlook across all metrics as provided in its financial results press release dated February 9, 2023, with MLR now projected to be towards the low-end of the 82% - 84% range and Adjusted EBITDA 1 projected to be towards the high-end of the ($175) million - ($75) million range, towards a ($75) million loss.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.